Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft.

Yadav, Vivek R

Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft. [electronic resource] - British journal of pharmacology Dec 2013 - 1436-48 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1476-5381

10.1111/bph.12406 doi


Adenocarcinoma--drug therapy
Adenocarcinoma of Lung
Animals
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Apoptosis Regulatory Proteins--metabolism
Benzylidene Compounds--pharmacology
Cell Line, Tumor
Dose-Response Relationship, Drug
Fluorodeoxyglucose F18
Gene Expression Regulation, Neoplastic
Humans
Inflammation Mediators--metabolism
Ki-67 Antigen--metabolism
Lung Neoplasms--drug therapy
Male
Mice
Mice, Nude
Multimodal Imaging
Phosphorylation
Piperidones--pharmacology
Positron-Emission Tomography
Signal Transduction--drug effects
Time Factors
Tomography, X-Ray Computed
Transcription Factor RelA--genetics
Transfection
Tumor Burden--drug effects
Xenograft Model Antitumor Assays